Background: Population-based information about cancer occurrence and survival are
required to inform clinical practice and research; but for most lymphomas data are lacking …

There are limited data characterizing the subtype‐specific incidence of lymphoid neoplasms
in the World Health Organization (WHO) Classification era. Data were obtained on all …

Collectively, lymphoid neoplasms are the fourth most common cancer and the sixth leading
cause of cancer death in the United States. The authors provide contemporary lymphoid …

It is well established that the male sex is associated with increased risk for, as well as poorer
survival of, most cancers. A similar pattern has been described in lymphomas but has not yet …

Roman E & Smith AG (2011) Histopathology 58, 4–14 Epidemiology of lymphomas
Epidemiological reports on lymphomas often begin, and sometimes end, by stating that little …

With diverse aetiologies, treatment pathways and outcomes, haematological malignancies
comprise a heterogeneous group of over 60 cancers. 1, 2 Critically for epidemiology …

Abstract Background Non-Hodgkin lymphoma (NHL), the most common hematologic
malignancy, consists of numerous subtypes. The etiology of NHL is incompletely …

Summary The Haematological Malignancy Research Network (HMRN) was established in
2004 to provide robust generalizable data to inform clinical practice and research. It …

With the incidence and prevalence of lymphoid neoplasms increasing, a comparison of
survival patterns by subtype may provide critical clues for improving the disease burden. We …

Background: Ascertainment of cases and disease classification is an acknowledged
problem for epidemiological research into haematological malignancies. Methods: The …